SCHEMBL11070645

SCHEMBL11070645

CCCCCCCCCC/C=C/CCCN(C(=O)C(F)(F)F)c1ccccc1C(=O)Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.41
CES1 P23141 2/20 0.41
ALDH1A1 P00352 2/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 2/20 0.40
PLA2G4A P47712 2/20 0.40
PLA2G4B P0C869 1/20 0.40
BLM P54132 1/20 0.40
MGLL Q99685 1/20 0.40
PLA2G4C Q9UP65 1/20 0.40
SOAT2 O75908 1/20 0.39
SOAT1 P35610 1/20 0.39
NPC1 O15118 1/20 0.38
JAK2 O60674 1/20 0.38
RAB9A P51151 1/20 0.38
PAX8 Q06710 1/20 0.38
EPHX2 P34913 4/20 0.37
F7 P08709 3/20 0.37
F3 P13726 3/20 0.37
MMP2 P08253 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11070648 1.00 FAAH (0.41) FAAHCES1ALDH1A1TP53MAPT
SCHEMBL11065689 0.90 F7 (0.42) FAAHCES1ALDH1A1TP53MAPT
SCHEMBL11065692 0.90 F7 (0.42) FAAHCES1ALDH1A1TP53MAPT
SCHEMBL11070777 0.87 SOAT2 (0.40) FAAHCES1ALDH1A1TP53MAPT
SCHEMBL11067675 0.83 FAAH (0.39) FAAHCES1ALDH1A1MAPTPLA2G4A
SCHEMBL11503194 0.81 ALDH1A1 (0.40) FAAHCES1ALDH1A1TP53MAPT
SCHEMBL11070795 0.80 FAAH (0.37) FAAHCES1ALDH1A1TP53MAPT
SCHEMBL11070793 0.80 FAAH (0.37) FAAHCES1ALDH1A1TP53MAPT
SCHEMBL11494060 0.80 FAAH (0.43) FAAHCES1ALDH1A1MAPTPLA2G4A
SCHEMBL11493715 0.80 FAAH (0.43) FAAHCES1ALDH1A1MAPTPLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4440940-A HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1984-04-03 US disclosed